Home » Topics » Regulatory » Patents

Patents
RSS

New wee1-like protein kinase inhibitors discovered at Nuvation Bio

Nov. 5, 2020

Memorial Sloan-Kettering Cancer Center presents CD19 antibodies

Nov. 5, 2020

New anti-CD40 antibodies described by Nankai University

Nov. 5, 2020

Sorrento Therapeutics synthesizes multispecific antigen-binding protein complexes

Nov. 5, 2020

New PROTACs synthesized by C4 Therapeutics

Nov. 4, 2020

Tenaya Therapeutics presents AAV5 compositions

Nov. 4, 2020

Nuvation Bio describes new Wee1 inhibitors

Nov. 4, 2020

Bristol Myers Squibb identifies new Gal-3 inhibitors

Nov. 4, 2020

Plexxikon discloses KAT3B and CREBBP inhibitors

Nov. 4, 2020

Nurix Therapeutics patents CBLB inhibitors

Nov. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...